Demonstration of low-titer anti-Pr cold agglutinins.
D000042:Absorption; D000328:Adult; D000373:Agglutinins / Q000032:analysis*; D001789:Blood Group Antigens; D002462:Cell Membrane; D003080:Cold Temperature; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006023:Glycoproteins / Q000032:analysis; D006385:Hemagglutination Inhibition Tests; D006386:Hemagglutination Tests; D006801:Humans; D007106:Immune Sera; D007074:Immunoglobulin G / Q000032:analysis; D007158:Immunologic Techniques; D007231:Infant, Newborn; D007518:Isoantibodies / Q000032:analysis*; D008623:Mercaptoethanol; D008875:Middle Aged; D009438:Neuraminic Acids / Q000032:analysis; D009439:Neuraminidase / Q000494:pharmacology; D010084:Oxidation-Reduction; D010206:Papain / Q000494:pharmacology; D010447:Peptide Hydrolases / Q000494:pharmacology; D010504:Periodic Acid; D011247:Pregnancy; D014734:Vibrio cholerae / Q000201:enzymology
D000373:Agglutinins; D001789:Blood Group Antigens; D006023:Glycoproteins; D007106:Immune Sera; D007074:Immunoglobulin G; D007518:Isoantibodies; D009438:Neuraminic Acids; D010504:Periodic Acid; D008623:Mercaptoethanol; D009439:Neuraminidase; D010447:Peptide Hydrolases; D010206:Papain